S-23 vs RAD-140: Research Insights and Differences

Introduction

S-23 and RAD-140 are both Selective Androgen Receptor Modulators (SARMs) known for their potential anabolic benefits. Despite ongoing research, they remain in the preclinical stage and are not approved for human use.

What Was S-23 Designed To Do?

S-23 was developed in academic research settings with the aim of creating a male contraceptive. It is known for its receptor selectivity, allowing it to precisely target certain androgen receptors and potentially reduce side effects compared to traditional anabolic steroids. However, it is still in the preclinical phase.

What Was RAD-140 Designed To Do?

Developed by Radius Health, RAD-140 is being studied for its potential in addressing muscle wasting and providing neuroprotective benefits. Like S-23, RAD-140 is still in the preclinical research stage and not approved for human use.

Key Differences

Aspect	S-23	RAD-140
Developer Origin	Academic	Biotech (Radius Health)
Intended Application	Male Contraceptive	Muscle Wasting, Neuroprotection
Research Stage	Preclinical	Preclinical
Human Data Availability	None	None

What Actually Separates Them?

The primary distinction between S-23 and RAD-140 lies in their therapeutic research focus. S-23 is mainly explored for contraceptive purposes, while RAD-140 targets muscle wasting and neuroprotection.

Legal + Disclaimer

Neither S-23 nor RAD-140 is approved for human consumption and should be used solely within controlled research environments. Consult a healthcare professional before considering any SARMs.